BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 34126955)

  • 1. Predictive factors for survival following stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumour thrombosis and construction of a nomogram.
    Li X; Ye Z; Lin S; Pang H
    BMC Cancer; 2021 Jun; 21(1):701. PubMed ID: 34126955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis.
    Shui Y; Yu W; Ren X; Guo Y; Xu J; Ma T; Zhang B; Wu J; Li Q; Hu Q; Shen L; Bai X; Liang T; Wei Q
    Radiat Oncol; 2018 Sep; 13(1):188. PubMed ID: 30253783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomogram predicting survival of hepatocellular carcinoma with portal vein tumour thrombus after curative resection.
    Hu Y; You S; Yang Z; Cheng S
    ANZ J Surg; 2019 Jan; 89(1-2):E20-E25. PubMed ID: 30117625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomogram for Individualized Prediction of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis on Conservative Treatment.
    Liu Y; Xue D; Zhang X; Gao F; Sun L; Yang X; Li Y; Zhang Q; Zhu B; Niu S; Huang Y; Hu Y; Wang X
    Biomed Res Int; 2020; 2020():1473718. PubMed ID: 32149077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional conformal radiotherapy for locally advanced hepatocellular carcinoma with portal vein tumour thrombosis: evaluating effectiveness of the model for end-stage liver disease (MELD) score compared with the Child-Pugh classification.
    Okazaki E; Yamamoto A; Nishida N; Hamuro M; Ogino R; Hosono M; Shimatani Y; Tsutsumi S; Hamamoto S; Sohgawa E; Jogo A; Miki Y
    Br J Radiol; 2016 Jul; 89(1063):20150945. PubMed ID: 27164029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of stereotactic body radiotherapy for portal vein tumor thrombosis in patients with hepatocellular carcinoma and underlying chronic liver disease.
    Choi HS; Kang KM; Jeong BK; Jeong H; Lee YH; Ha IB; Song JH
    Asia Pac J Clin Oncol; 2021 Jun; 17(3):209-215. PubMed ID: 32757461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area.
    Im JH; Yoon SM; Park HC; Kim JH; Yu JI; Kim TH; Kim JW; Nam TK; Kim K; Jang HS; Kim JH; Kim MS; Yoon WS; Jung I; Seong J
    Liver Int; 2017 Jan; 37(1):90-100. PubMed ID: 27317941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is hepatocellular carcinoma complicated with portal vein tumor thrombosis potentially curable by radiotherapy in the form of stereotactic body radiation therapy?
    Srivastava A; Parambath HK; Ramdulari AV; Saxena H; Kumar R; Pandey S; Shalimar ; Gupta S; Jee B
    Int J Radiat Biol; 2022; 98(10):1495-1509. PubMed ID: 35311612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
    Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
    Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative Stereotactic Body Radiotherapy to Portal Vein Tumour Thrombus in Hepatocellular Carcinoma: Clinical and Pathological Analysis.
    Kishi N; Kanayama N; Hirata T; Ohira S; Wada K; Kawaguchi Y; Konishi K; Nagata S; Nakatsuka SI; Marubashi S; Tomokuni A; Wada H; Kobayashi S; Tomita Y; Teshima T
    Sci Rep; 2020 Mar; 10(1):4105. PubMed ID: 32139751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombosis.
    Xi M; Zhang L; Zhao L; Li QQ; Guo SP; Feng ZZ; Deng XW; Huang XY; Liu MZ
    PLoS One; 2013; 8(5):e63864. PubMed ID: 23737955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of stereotactic body radiation therapy with and without sorafenib as treatment for hepatocellular carcinoma with portal vein tumor thrombosis.
    Que J; Wu HC; Lin CH; Huang CI; Li LC; Ho CH
    Medicine (Baltimore); 2020 Mar; 99(13):e19660. PubMed ID: 32221093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic index for portal vein tumor thrombosis in patients with hepatocellular carcinoma treated with radiation therapy.
    Yu JI; Park HC; Lim DH; Park W; Yoo BC; Paik SW; Koh KC; Lee JH
    J Korean Med Sci; 2011 Aug; 26(8):1014-22. PubMed ID: 21860551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overall response of both intrahepatic tumor and portal vein tumor thrombosis is a good prognostic factor for hepatocellular carcinoma patients receiving concurrent chemoradiotherapy.
    Choi Y; Kim JW; Cha H; Han KH; Seong J
    J Radiat Res; 2014 Jan; 55(1):113-20. PubMed ID: 23772086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
    Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
    Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiotherapy versus intensity-modulated radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis.
    Li LQ; Zhou Y; Huang Y; Liang P; Liang SX; Su TS
    Hepatol Int; 2021 Jun; 15(3):630-641. PubMed ID: 33818714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience With LDLT in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis Postdownstaging.
    Soin AS; Bhangui P; Kataria T; Baijal SS; Piplani T; Gautam D; Choudhary NS; Thiagarajan S; Rastogi A; Saraf N; Saigal S
    Transplantation; 2020 Nov; 104(11):2334-2345. PubMed ID: 32032291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis Nomogram for Hepatocellular Carcinoma Patients with Portal Vein Invasion Undergoing Transarterial Chemoembolization Plus Sorafenib Treatment: A Retrospective Multicentre Study.
    Zhang L; Sun JH; Hou ZH; Zhong BY; Yang MJ; Zhou GH; Wang WS; Huang P; Zhang S; Li Z; Zhu XL; Yan ZP; Ni CF
    Cardiovasc Intervent Radiol; 2021 Jan; 44(1):63-72. PubMed ID: 32965582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
    Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
    [No Abstract]   [Full Text] [Related]  

  • 20. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.